These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting Onco Targets Ther; 2021; 14():3177. PubMed ID: 34040385 [TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of SLP-2 in Hepatocellular Carcinoma Tissues and Its Regulation in Cancer Cell Proliferation, Migration, and EMT [Retraction]. Onco Targets Ther; 2022; 15():869-870. PubMed ID: 36003327 [TBL] [Abstract][Full Text] [Related]
18. miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways [Retraction]. Onco Targets Ther; 2024; 17():305-306. PubMed ID: 38617089 [TBL] [Abstract][Full Text] [Related]
19. MLPH Accelerates the Epithelial-Mesenchymal Transition in Prostate Cancer [Retraction]. Onco Targets Ther; 2023; 16():1051-1052. PubMed ID: 38116521 [TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of LINC01296 in Pan-Cancers and the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation [Retraction]. Onco Targets Ther; 2020; 13():2525. PubMed ID: 32273722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]